Cutera (NASDAQ:CUTR) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Price Performance

Shares of CUTR stock opened at $0.41 on Wednesday. The company has a market cap of $8.34 million, a PE ratio of -0.06 and a beta of 1.31. Cutera has a 1 year low of $0.28 and a 1 year high of $3.10. The stock’s 50 day simple moving average is $0.41 and its two-hundred day simple moving average is $0.68.

Cutera (NASDAQ:CUTR) last released its quarterly earnings results on Thursday, November 7th. The medical device company reported ($1.94) earnings per share for the quarter, missing the consensus estimate of ($0.96) by ($0.98). The company had revenue of $32.50 million during the quarter, compared to the consensus estimate of $32.57 million. During the same quarter in the previous year, the firm earned ($2.22) EPS. Equities research analysts expect that Cutera will post -5.78 EPS for the current year.

Hedge Funds Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Squarepoint Ops LLC raised its holdings in shares of Cutera, Inc. (NASDAQ:CUTR) by 164.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 113,964 shares of the medical device company’s stock after buying an additional 70,870 shares during the period. Squarepoint Ops LLC owned about 0.57% of Cutera worth $172,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.